Wednesday, February 26 2020, 05:32 am
GSK Public policy positions

GSK Public policy positions

Cloning and Stem Cell Technologies The Issue Cloning and stem cell technologies continue to develop at pace. The cloning of whole organisms (bacteria, fungi, plants and animals) is now commonplace for research purposes. The use of stem cells (see Annex A) to treat diseases and disorders has also increased substantially over recent years.